Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |